[…]
Read More… from Why Bioclinica tapped AI in immunotherapy trials early in the pandemic
EP Type: Trade Publication
Contains all external trade publications
Transforming clinical event adjudication in the era of COVID-19
Opportunities abound with ‘rescue’ studies
Demystifying submissions of eCOA documentation for ethics review: Are we making submissions more difficult than necessary
Assessing suicide risk in clinical trials: The patient knows best